American International Group’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,949
| Closed | -$751K | – | 2979 |
|
|
2024
Q1 | $751K | Buy |
18,949
+2,764
| +17% | +$81.6K | ﹤0.01% | 1447 |
|
|
2023
Q4 | $308K | Buy |
16,185
+343
| +2% | +$4.76K | ﹤0.01% | 1923 |
|
|
2023
Q3 | $181K | Buy |
15,842
+563
| +4% | +$6.93K | ﹤0.01% | 2180 |
|
|
2023
Q2 | $157K | Buy |
15,279
+3,861
| +34% | +$34.8K | ﹤0.01% | 2313 |
|
|
2023
Q1 | $88.1K | Buy |
11,418
+708
| +7% | +$5.64K | ﹤0.01% | 2520 |
|
|
2022
Q4 | $78.7K | Buy |
10,710
+3,295
| +44% | +$21.1K | ﹤0.01% | 2606 |
|
|
2022
Q3 | $53K | Buy |
7,415
+105
| +1% | +$865 | ﹤0.01% | 2797 |
|
|
2022
Q2 | $62K | Buy |
7,310
+1,543
| +27% | +$13.3K | ﹤0.01% | 2809 |
|
|
2022
Q1 | $52K | Sell |
5,767
-406
| -7% | -$3.51K | ﹤0.01% | 2828 |
|
|
2021
Q4 | $85K | Sell |
6,173
-185
| -3% | -$2.29K | ﹤0.01% | 2790 |
|
|
2021
Q3 | $68K | Sell |
6,358
-151
| -2% | -$1.39K | ﹤0.01% | 2930 |
|
|
2021
Q2 | $59K | Buy |
+6,509
| New | +$70.7K | ﹤0.01% | 2981 |
|
|
2016
Q2 | – | Sell |
-720
| Closed | -$12K | – | 4567 |
|
|
2016
Q1 | $12K | Buy |
+720
| New | +$14.4K | ﹤0.01% | 4493 |
|
American International Group's ALPN Position: Q2 2024 in Review
American International Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 18,949 shares — an estimated $751K sold.
American International Group first reported a position in ALPN in Q1 2016 and held it in 13 quarters. The position peaked at $751K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- American International Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- American International Group sold 18,949 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $751K.
- American International Group first reported a position in Alpine Immune Sciences Inc in Q1 2016 and held it in 13 quarters.
- American International Group's Alpine Immune Sciences Inc position peaked at $751K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.